HopeStage
Back to all studies
CompletedNCT00000244

Dynorphin for heroin withdrawal and craving

About this titleRead the official source — NCT00000244
Medication studyAges 18–55United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
MinneapolisSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 1994
Recruitment status
Completed
Enrollment listed in the registry
0
Sponsor
University of Minnesota
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT00000244
Official title
Show the full official title

Effects of Dynorphin 1-13 on Heroin Addiction

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Minneapolis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Minnesota, a university.

Did this study involve medication?

Yes. The study involved medication, including Dynorphin 1 - 13.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies